Skip to main content
. 2022 Apr 12;23:100446. doi: 10.1016/j.lanwpc.2022.100446

Table 3.

Patient and isolate characteristics.

Characteristic N (%) or alternative parameter
Total no. of isolates included 2275
Total no. of patients included 1970
Age (median, IQR) 65 years (47 – 77yrs)
Male sex (no., %) 1063 (56·8%)
Sample collected for clinical purposes (suspected infection) 1428 (62·8%)
Sample collected for MDRO screening purposes 847 (37·2%)
Time from admission to isolate collection (median, IQR) 3 days (1 – 12 days)
Ward where sample was collected All samples (% total samples) Clinical samples (% per ward) Screening samples (% per ward)
Intensive care unit 373 (16·4%) 117 (31·4%) 256 (68·6%)
Other high-risk warda 434 (19·1%) 121 (27·9%) 313 (72·1%)
General acute wardb 1090 (47·9%) 865 (79·4%) 225 (20·6%)
Emergency department 209 (9·2%) 204 (97·6%) 5 (2·4%)
Subacute care wardc 169 (7·4%) 121 (71·6%) 48 (28·4%)

MDRO, multidrug-resistant organism; IQR, interquartile range.

a

High-risk wards, includes haematology, oncology, renal ward (including renal transplant), and liver transplant wards.

b

General acute wards, include all wards not designated as ICU, high-risk or subacute.

c

Subacute care, includes aged care, rehabilitation, palliative care and spinal wards.